Innovations

 Dry aersol technology

STERINIS® the optimises process disinfection, Gloster Sante Europe developed a new technology innovating through a couple apparatus/produced (Sterinis®/Sterusil®) intended to fight against the recurrence of the contamination of the environment of the patient.

The studies carried out by Gloster Santé Europe Company (1999 to 2003) as regards research and development made it possible to develop a specific diffusion device which obtain a perfect and homogeneous diffusion of one disinfecting in the whole of volume and treated surfaces, including those usually inaccessible or hidden. This technique ensures a degree of disinfection of the patient’s environment superior to anything known up to now, as it completely and evenly disperses the disinfectant over all surfaces present (using the aerospray principle).

It thoroughly disinfects 'the surfaces and volumes that other treatments can’t reach'.

'Dry Mist' technology guarantees massive destruction of micro-organisms by bringing the diffused disinfectant[1] into contact with all surfaces present through:

Ionisation:  The aerospray system developed by Gloster Santé Europe produces an aerosol-quality mist (with droplets between 8µ and 12µ), with electrically charged droplets which facilitate the nucleation process

Nucleation:  Nucleation is the process whereby extremely small droplets adhere to particles in the atmosphere and also to surfaces by creating an interface between the droplet and the particle or surface on the one hand, and between the substance in gaseous phase and the droplet of the liquid on the other hand.

This innovation avoids all inherent risks of errors due to the human interventions.